KLRA - Kailera Therapeutics, Inc. Common Stock -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg ยท closes rebased to 100 at each year's first session
Ticker Details
Kailera Therapeutics, Inc. Common Stock
IPO Date: April 17, 2026
Sector: Healthcare
Industry: Biotech
Market Cap: $1.66B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.74 | 3.75%
Avg Daily Range (30 D): $0.67 | 3.99%
Avg Daily Range (90 D): $0.73 | 3.84%
Institutional Daily Volume
Avg Daily Volume: .62M
Avg Daily Volume (30 D): .64M
Avg Daily Volume (90 D): .53M
Trade Size
Avg Trade Size (Sh.): 74
Avg Trade Size (Sh.) (30 D): 67
Avg Trade Size (Sh.) (90 D): 66
Institutional Trades
Total Institutional Trades: 162
Avg Institutional Trade: $3.03M
Avg Institutional Trade (30 D): $1.89M
Avg Institutional Trade (90 D): $2.61M
Avg Institutional Trade Volume: .15M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $3.5M
Avg Closing Trade (30 D): $2.07M
Avg Closing Trade (90 D): $3.06M
Avg Closing Volume: 174.96K
 
News
Jun 16, 2026 @ 7:30 AM
3 Under-the-Radar Stocks to Buy and Hold for a Dec...
Source: Prosper Junior Bakiny
Jun 5, 2026 @ 11:32 PM
Hengrui Pharma and Kailera Therapeutics Present Ri...
Source: Na
May 16, 2026 @ 2:30 PM
Is Kailera Therapeutics a Buy After Its Sizzling I...
Source: Jack Delaney
Apr 23, 2026 @ 4:08 PM
Kailera Therapeutics' Strong IPO Validates "NewCo"...
Source: Bamboo Works
Apr 20, 2026 @ 8:05 PM
Kailera Announces Closing of Initial Public Offeri...
Source: Na
Financials
  TTM N/A N/A
Basic EPS $-1.09
Diluted EPS $-1.09
Revenue $M
Gross Profit
Net Income / Loss $-111.31M
Operating Income / Loss $-121.37M
Cost of Revenue
Net Cash Flow $18.48M
PE Ratio